EMR Versus ESD for Resection of Large Distal Non-pedunculated Colorectal Adenomas
MATILDA
Multicenter, Randomised Controlled Trial Comparing Endoscopic Mucosal Resection (EMR) And Endoscopic Submucosal dissecTIon (ESD) for Resection of Large Distal Non-pedunculated Colorectal Adenomas (MATILDA-trial)
2 other identifiers
interventional
212
1 country
1
Brief Summary
Endoscopic resection of adenomas in the colon is the cornerstone of effective colorectal cancer prevention. Endoscopic mucosal resection (EMR) is currently the most used technique for resection of large distal colorectal adenomas, however, maintains some important limitations. In large lesions, EMR can often only be performed in a piecemeal fashion resulting in relatively low R0-resection rates and high recurrence rates. Endoscopic submucosal dissection (ESD) is a newer procedure that is more difficult resulting in a longer procedural time, but is promising due to the high en-bloc resection rates and the very low recurrence rates. The aim of this multicenter randomized study is to compare EMR and ESD with regard to recurrence rates and radical (R0) resection rates, and to put this into perspective against the costs and complication rates of both strategies and the burden perceived by patients on the long term-term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 8, 2016
CompletedFirst Posted
Study publicly available on registry
January 15, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedOctober 26, 2016
October 1, 2016
2.4 years
January 8, 2016
October 24, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence rate at follow-up colonoscopy after 6 months
Observed from resected residual disease or, if not present, from biopsies of the scar
6 months
Secondary Outcomes (6)
Long-term recurrence rate at follow-up colonoscopy after 36 months
36 months
Health care resource utilization and consts
36 months
Perceived burden and quality of life among patients
36 months
Complication rate
30 days
Surgical referral rate
36 months
- +1 more secondary outcomes
Study Arms (2)
EMR
ACTIVE COMPARATORIn the EMR-arm, endoscopic resection will be performed using the (p)EMR technique.
ESD
ACTIVE COMPARATORIn the ESD-arm, endoscopic resection will be performed using the (h)ESD technique.
Interventions
Eligibility Criteria
You may qualify if:
- non-pedunculated polyp larger than 20 mm in the rectum, sigmoid or descending colon found during colonoscopy
- indication for endoscopic treatment
- ≥18 years old
- Written informed consent
You may not qualify if:
- suspicion of malignancy, as determined by endoscopic findings (invasive Kudo pit pattern, Hiroshima type C) or proven malignancy at histology
- prior endoscopic resection attempt
- presence of synchronous distal advanced carcinoma that requires surgical resection
- the risk exceeds the benefit of endoscopic treatment, such as patient's with an extremely poor general condition or a very short life expectancy
- the inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- UMC Utrechtlead
- Comprehensive Cancer Centre The Netherlandscollaborator
Study Sites (1)
UMC Utrecht
Utrecht, Utrecht, 3508GA, Netherlands
Related Publications (1)
Backes Y, Moons LM, van Bergeijk JD, Berk L, Ter Borg F, Ter Borg PC, Elias SG, Geesing JM, Groen JN, Hadithi M, Hardwick JC, Kerkhof M, Mangen MJ, Straathof JW, Schroder R, Schwartz MP, Spanier BW, de Vos Tot Nederveen Cappel WH, Wolfhagen FH, Koch AD. Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial. BMC Gastroenterol. 2016 May 26;16(1):56. doi: 10.1186/s12876-016-0468-6.
PMID: 27229709DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
L.M.G. Moons, MD, PhD
UMC Utrecht
- PRINCIPAL INVESTIGATOR
A.D. Koch, MD, PhD
Erasmus Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- dr. L.M.G. Moons, Principal Investigator
Study Record Dates
First Submitted
January 8, 2016
First Posted
January 15, 2016
Study Start
April 1, 2016
Primary Completion
September 1, 2018
Study Completion
December 1, 2020
Last Updated
October 26, 2016
Record last verified: 2016-10